Assignee
CEPHALON INC
US·186 granted patents·65 pending applications·4,554 citations·filing 1989–2021
Top patents by PatentIndex Score
251 records- 0197US8344006B2Liquid formulations of bendamustineCEPHALON INC·Filed 2012·Granted Jan 1, 2013·51 cites·10 claims
- 0297US6630500B2Selected fused pyrrolocarbazolesCEPHALON INC·Filed 2001·Granted Oct 7, 2003·162 cites·37 claims
- 0396US5648335APrevention and treatment of peripheral neuropathyCEPHALON INC·Filed 1996·Granted Jul 15, 1997·155 cites·3 claims
- 0496US5591855AFused pyrrolocarbazolesCEPHALON INC·Filed 1995·Granted Jan 7, 1997·115 cites·16 claims
- 0596US5498616ACysteine protease and serine protease inhibitorsCEPHALON INC·Filed 1994·Granted Mar 12, 1996·79 cites·18 claims
- 0696US5475110AFused PyrrolocarbazolesCEPHALON INC·Filed 1994·Granted Dec 12, 1995·93 cites·18 claims
- 0796US5093317ATreating disorders by application of insulin-like growth factorCEPHALON INC·Filed 1989·Granted Mar 3, 1992·212 cites·4 claims
- 0895US10138296B2Antibodies that specifically bind to TL1ACEPHALON INC·Filed 2016·Granted Nov 27, 2018·17 cites·34 claims
- 0995US8791270B2Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2013·Granted Jul 29, 2014·31 cites·23 claims
- 1095US6399780B1Isomeric fused pyrrolocarbazoles and isoindolonesCEPHALON INC·Filed 2000·Granted Jun 4, 2002·61 cites·19 claims
- 1195US6346548B1Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigueCEPHALON INC·Filed 2000·Granted Feb 12, 2002·89 cites·12 claims
- 1294US7276246B2Dissolvable backing layer for use with a transmucosal delivery deviceCEPHALON INC·Filed 2004·Granted Oct 2, 2007·60 cites·25 claims
- 1394US5869336ARecombinant enzymatically active calpain expressed in a baculovirus systemCEPHALON INC·Filed 1997·Granted Feb 9, 1999·168 cites·9 claims
- 1494US5569648APrevention and treatment of peripheral neuropathyCEPHALON INC·Filed 1994·Granted Oct 29, 1996·103 cites·5 claims
- 1593US11220549B2Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseasesCEPHALON INC·Filed 2018·Granted Jan 11, 2022·8 cites·31 claims
- 1693US8669279B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2013·Granted Mar 11, 2014·17 cites·22 claims
- 1793US8609863B2Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2012·Granted Dec 17, 2013·21 cites·4 claims
- 1893US7306812B2Dissolvable backing layer for use with a transmucosal delivery deviceCEPHALON INC·Filed 2004·Granted Dec 11, 2007·46 cites·60 claims
- 1993US7074793B2Cyclic substituted fused pyrrolocarbazoles and isoindolonesCEPHALON INC·Filed 2004·Granted Jul 11, 2006·60 cites·25 claims
- 2093US6455525B1Heterocyclic substituted pyrazolonesCEPHALON INC·Filed 2000·Granted Sep 24, 2002·63 cites·20 claims
- 2192US8883836B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2014·Granted Nov 11, 2014·12 cites·22 claims
- 2292US7601716B2Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitorsCEPHALON INC·Filed 2007·Granted Oct 13, 2009·23 cites·19 claims
- 2392US6488164B2Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigueCEPHALON INC·Filed 2001·Granted Dec 3, 2002·45 cites·12 claims
- 2492US6455588B1Compositions including modafinil for treatment of eating disorders and for appetite stimulationCEPHALON INC·Filed 2000·Granted Sep 24, 2002·52 cites·30 claims
- 2592US6359130B1Bridged indenopyrrolocarbazolesCEPHALON INC·Filed 2000·Granted Mar 19, 2002·48 cites·14 claims
- 2692US6310057B1α-ketoamide multicatalytic protease inhibitorsCEPHALON INC·Filed 2000·Granted Oct 30, 2001·31 cites·32 claims
- 2792US5550262AMulticatalytic protease inhibitorsCEPHALON INC·Filed 1994·Granted Aug 27, 1996·52 cites·10 claims
- 2891US8895756B2Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2012·Granted Nov 25, 2014·13 cites·4 claims
- 2991US6875893B2Preparations of a sulfinyl acetamideCEPHALON INC·Filed 2003·Granted Apr 5, 2005·28 cites·27 claims
- 3091US6492396B2Substituted thioacetamidesCEPHALON INC·Filed 2001·Granted Dec 10, 2002·47 cites·24 claims
- 3191US5633228APrevention and treatment of peripheral neuropathyCEPHALON INC·Filed 1994·Granted May 27, 1997·73 cites·3 claims
- 3291US5594009AFused pyrrolocarbazolesCEPHALON INC·Filed 1995·Granted Jan 14, 1997·63 cites·27 claims
- 3390US9902696B21,4-substituted piperidine derivativesCEPHALON INC·Filed 2016·Granted Feb 27, 2018·7 cites·21 claims
- 3490US5705511AFused pyrrolocarbazolesCEPHALON INC·Filed 1995·Granted Jan 6, 1998·100 cites·69 claims
- 3589US6670358B2Substituted thioacetamidesCEPHALON INC·Filed 2001·Granted Dec 30, 2003·32 cites·29 claims
- 3689US6548062B2Method of treating cancer with anti-neurotrophin agentsCEPHALON INC·Filed 2001·Granted Apr 15, 2003·89 cites·15 claims
- 3789US5461146ASelected protein kinase inhibitors for the treatment of neurological disordersCEPHALON INC·Filed 1993·Granted Oct 24, 1995·71 cites·4 claims
- 3888US7576206B2Proteasome inhibitors and methods of using the sameCEPHALON INC·Filed 2004·Granted Aug 18, 2009·23 cites·1 claims
- 3988US7446122B2Substituted indole derivativesCEPHALON INC·Filed 2004·Granted Nov 4, 2008·29 cites·37 claims
- 4088US6919378B2Pharmaceutical solutions of modafinil compoundsCEPHALON INC·Filed 2002·Granted Jul 19, 2005·39 cites·31 claims
- 4188US6489363B2Pharmaceutical solutions of modafinil compoundsCEPHALON INC·Filed 2001·Granted Dec 3, 2002·36 cites·39 claims
- 4287US9533955B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2016·Granted Jan 3, 2017·4 cites·12 claims
- 4387US9339502B2Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitorCEPHALON INC·Filed 2015·Granted May 17, 2016·5 cites·21 claims
- 4487US9132128B2Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitorCEPHALON INC·Filed 2014·Granted Sep 15, 2015·7 cites·20 claims
- 4587US7919502B2Pyridopyrazines and derivatives thereof as ALK and c-MET inhibitorsCEPHALON INC·Filed 2009·Granted Apr 5, 2011·9 cites·8 claims
- 4687US6919367B2Substituted thioacetamidesCEPHALON INC·Filed 2003·Granted Jul 19, 2005·24 cites·35 claims
- 4787US6500802B1Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitorsCEPHALON INC·Filed 2000·Granted Dec 31, 2002·28 cites·30 claims
- 4887US6288231B1Peptide-containing α-ketoamide cysteine and serine protease inhibitorsCEPHALON INC·Filed 2000·Granted Sep 11, 2001·19 cites·5 claims
- 4986US9623026B2Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitorCEPHALON INC·Filed 2016·Granted Apr 18, 2017·4 cites·10 claims
- 5086US5990083AMulticatalytic protease inhibitorsCEPHALON INC·Filed 1997·Granted Nov 23, 1999·50 cites·11 claims
Showing the top 50 of 251 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CEPHALON INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →